Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
about
Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis preventionMolecularly targeted drugs for metastatic colorectal cancerAssociation between Polymorphisms in Vascular Endothelial Growth Factor Gene and Response to Chemotherapies in Colorectal Cancer: A Meta-AnalysisRelationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancerPersonalizing medicine for metastatic colorectal cancer: current developments.Targeted inhibition of VEGF receptor 2: an update on ramucirumab.MicroRNA regulation network in colorectal cancer metastasisUpdate on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib.Ziv-aflibercept in metastatic colorectal cancerDeciphering the anti-angiogenic effect of endostatin/cyclophosphamide to normalize tumor micrangium through notch signaling pathway in colon cancer.Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxiaKRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer.Quince peel polyphenolic extract blocks human colon adenocarcinoma LS174 cell growth and potentiates 5-fluorouracil efficacy.Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma.A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatmentsHypercoagulation in colorectal cancer: what can platelet indices tell us?Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer.Impact of the prolymphangiogenic crosstalk in the tumor microenvironment on lymphatic cancer metastasis.Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways.Genotypic and phenotypic signatures to predict immune checkpoint blockade therapy response in patients with colorectal cancer.Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell Line.Research progress on common adverse events caused by targeted therapy for colorectal cancer.New Trends in the Therapeutic Approach to Metastatic Colorectal Cancer.Angiogenesis: Managing the Culprits behind Tumorigenesis and Metastasis
P2860
Q21195742-27948874-FA8D-4A0C-AE71-28DB2CD37527Q26828735-7B5A98AE-9D2A-4657-8A91-09B89AF04821Q26862559-6BA91AD9-53E4-4824-B00D-F2F88BBC5A6BQ28068654-40129E95-92CE-4677-943F-7286C9A92933Q34036665-A1BAD461-E282-48ED-8239-47168A2BE214Q34040956-92C064E4-8DF8-497C-98D2-EC863E68BFCCQ34161573-7E405845-D55E-43D3-9D91-254930340365Q34348270-E8F87791-38F8-4EEE-9800-B2E6DFC4A37DQ34658579-3A65BA0A-D7C7-42B1-89FC-E793DAA41684Q35893143-0995ADAE-AE1E-4485-B311-F58B93B3EC52Q36100135-86769F78-9166-4FD4-9DC6-4E39CA1F81C6Q36318292-1326D70C-F9C3-4B30-B9D4-B45187D72FE8Q36531205-9E5F3A75-F5A0-4638-A7D2-49883ABCBA00Q36710074-58F80FB0-9140-4B8F-85D7-78661EF27397Q36740744-B922FEB0-3E75-486E-B832-45358B95DBDEQ38246328-882ABC80-5086-4201-B5B2-759A559E698CQ41231221-0E877E4F-8471-4478-8D79-425E5E1B6E52Q42281477-5297D5F8-6533-4DF2-BFF4-316295CFC44AQ46014528-A5368E3D-9765-4E03-BBBB-5CCBEBD12F1BQ52666692-EB16D4EA-C1D5-47F1-B941-CB22D5C0DB0DQ55286501-4856A7C0-C822-4097-B7F5-60DB88982AD9Q55360813-34AD1EB1-A782-4B07-B6C4-5D6298515D7EQ55367746-48C6698B-3D3C-4FA3-91D9-40C349E10B73Q57825996-F83535D7-E41B-4C82-A015-72AC8F18748A
P2860
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
@ast
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
@en
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
@nl
type
label
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
@ast
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
@en
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
@nl
prefLabel
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
@ast
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
@en
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
@nl
P2860
P3181
P356
P1476
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
@en
P2093
Weijing Sun
P2860
P2888
P3181
P356
10.1186/1756-8722-5-63
P407
P5008
P577
2012-10-11T00:00:00Z
P5875
P6179
1053543992